RainDrop Digital PCR System Named a Top 10 Innovation for 2014 by The Scientist
News Dec 01, 2014
RainDance Technologies, Inc. has announced that The Scientist has named its RainDrop® Digital PCR System a Top 10 Innovation for 2014. RainDance is a repeat award winner of The Scientist Top 10 Innovation Award, having been recognized for its ThunderStorm® Next-Generation Sequencing (NGS) Content Enrichment System in 2011.
Now in the seventh year of the competition, The Scientist recognizes select innovative technologies and companies that have introduced truly revolutionary products for researchers in the past year. The winners are selected by an expert panel of independent judges who evaluated a broad range of novel laboratory tools, technologies, software, methodologies, and products.
The RainDrop Digital PCR System was selected as the industry’s most sensitive detection and analysis platform for DNA, RNA and microRNA. Capable of generating more than a billion reactions in a single day using RainDance’s proven digital droplet technology, the RainDrop System enables ultra-sensitive detection of molecular biomarkers for important research applications in oncology, viruses, pathogens, and immunology. RainDrop provides absolute quantitation for multiple types of nucleic acid analysis including rare alleles, gene expression, copy number variation, structural variations, and methylation. The RainDrop System has been adopted by leading cancer centers, academic and translational research, infectious disease centers, pharmaceutical companies, and industrial customers worldwide.
“We are honored to be among The Scientist’s top 10 innovations for the second time in four years. Being recognized alongside innovative products by Illumina, BioNano Genomics, and Leica reinforces our track record of pushing the boundaries of technology in life sciences,” said Roopom Banerjee, RainDance President and CEO. “We believe our RainDrop System will unlock cell-free research applications for liquid biopsy, enabling the detection and tracking of important disease biomarkers in bodily fluids.”
Attacking Telomeres Offers First Effective Glioblastoma TherapyNews
Blocking TRF1 – a telomere protector – interrupts tumour growth and increases survival in various mouse models of glioblastoma.READ MORE